Investment Summary

Dai-ichi Life Invests In Typica

On April 30, 2024, Dai-ichi Life invested in internet software and services company Typica

Investment Highlights
  • This is Dai-ichi Life’s 1st transaction in the Internet Software and Services sector.
  • This is Dai-ichi Life’s 2nd transaction in Japan.

Investment Summary
Date 2024-04-30
Target Typica
Sector Internet Software and Services
Investor(s) Dai-ichi Life
Deal Type Growth Capital

Target

Typica

Osaka, Japan
Typica operates an online platform that bridges coffee bean producers in developing countries with roasters in advanced countries, enabling direct trade of coffee beans between them. Typica is based in Osaka, Japan.

Search 198,435 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Dai-ichi Life

Tokyo, Japan
Category Company
Founded 1902
Sector Insurance
Employees59,495
Revenue 10.49T JPY (2024)
DESCRIPTION

Dai-ichi Life is a life insurance company. Dai-ichi offers underwriting of insurance policies, including personal insurance, individual annuity insurance, group insurance, group pension insurance, other insurances and reinsurance. Dai-ichi Life was founded in 1902 and is based in Tokyo, Japan.

DEAL STATS #
Overall 5 of 5
Sector (Internet Software and Services) 1 of 1
Type (Growth Capital) 2 of 2
Country (Japan) 2 of 2
Year (2024) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-07 Rakuten Medical

San Diego, California, United States

Rakuten Medical is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in preclinical studies have shown to lead to rapid and selective cell killing and tumor necrosis. Illuminox therapies have not yet been approved by any regulatory authority. Rakuten Medical was formed in 2010 and is based in San Diego, California.

Buy -
Mergr

Product

Company

Legal